Cardiology Devices - Southern Europe

  • Southern Europe
  • The projected revenue for the Cardiology Devices market market in Southern Europe is estimated to reach US$4.80bn by the year 2024.
  • It is expected to exhibit a compound annual growth rate (CAGR 2024-2029) of 5.05%, leading to a market volume of US$6.14bn by 2029.
  • When compared globally, the United States is anticipated to generate the highest revenue, with a projected amount of US$25,770.00m in 2024.
  • In Southern Europe, Portugal is paving the way for innovative cardiology devices through its strong focus on research and development in the medical technology sector.

Key regions: Spain, United Kingdom, China, United States, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Cardiology Devices market in Southern Europe is experiencing steady growth due to increasing customer preferences for advanced technology and the rising prevalence of cardiovascular diseases in the region.

Customer preferences:
Customers in Southern Europe are increasingly demanding innovative and technologically advanced cardiology devices. They are looking for devices that provide accurate diagnosis and treatment options for various cardiovascular conditions. Additionally, customers are also seeking devices that are minimally invasive, allowing for quicker recovery and reduced hospital stays.

Trends in the market:
One of the key trends in the Cardiology Devices market in Southern Europe is the adoption of minimally invasive procedures. This trend is driven by the desire to reduce patient discomfort and recovery time, as well as the cost-effectiveness of these procedures. As a result, there is a growing demand for devices such as catheters, stents, and implantable cardioverter-defibrillators (ICDs) that enable minimally invasive interventions. Another trend in the market is the increasing use of remote monitoring and telemedicine solutions. These technologies allow healthcare providers to remotely monitor patients with cardiovascular diseases and provide timely interventions when necessary. This trend is particularly relevant in Southern Europe, where access to healthcare services may be limited in rural areas or during emergencies.

Local special circumstances:
Southern Europe has a high prevalence of cardiovascular diseases, including coronary artery disease, hypertension, and heart failure. This is partly attributed to the aging population and lifestyle factors such as poor diet, lack of exercise, and smoking. As a result, there is a growing need for cardiology devices that can effectively diagnose and treat these conditions. Furthermore, Southern Europe has a well-established healthcare infrastructure, which facilitates the adoption of advanced cardiology devices. The region has a strong network of hospitals, clinics, and specialized cardiac centers that can provide specialized care to patients with cardiovascular diseases.

Underlying macroeconomic factors:
The Cardiology Devices market in Southern Europe is also influenced by underlying macroeconomic factors. The region has been recovering from the economic crisis in recent years, leading to increased healthcare spending and investment in medical technologies. Additionally, government initiatives and policies aimed at improving healthcare access and quality also contribute to the growth of the market. In conclusion, the Cardiology Devices market in Southern Europe is driven by customer preferences for advanced technology, the rising prevalence of cardiovascular diseases, and the adoption of minimally invasive procedures and remote monitoring solutions. The region's well-established healthcare infrastructure and recovering economy further support the growth of the market.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)